LDL Cholesterol Lowering With Evolocumab in Hypercholesterolemia

This observational extension of the OSLER-1 randomized clinical trial determines whether low-density lipoprotein cholesterol level reductions with evolocumab persist across different patient populations.

Read the full article here

Related Articles